The endogenous CaMK-II inhibitor 1 (CAMK2N1) acts as a tumor suppressor, inhibiting ErbB2 downstream signaling pathways and hence cell proliferation and other cellular functions. The gene discussed is ERBB2; the disease is neoplasm.